We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Behavioral Neuroscience – News and Features

News

Micro RNA Implicated as Molecular Factor in Alcohol Tolerance

A new study now indicates that microRNA may influence the development of alcohol tolerance, a hallmark of alcohol abuse and dependence.
News

Increased Burden of Rare Genetic Variations Found in Schizophrenia

Two new sites of deletions implicated in the study that triples the number of genomic areas definitely linked to schizophrenia.
News

deCODE and SGENE Consortium Discover Deletions in the Human Genome Linked to Risk of Schizophrenia

Findings may provide the foundation for a test to complement standard clinical diagnosis, potentially enabling earlier intervention and treatment.
News

Liver Damage in Hepatitis C Patients Could be Treated with Warfarin

The drug warfarin may help prevent liver failure in thousands of people with Hepatitis C, according to new research.
News

Mechanism for Postpartum Depression Found in Mice

Researchers have pinpointed a mechanism in the brains of mice that could explain why some human mothers become depressed following childbirth.
News

Alzheimer's Disease Patients Show Improvement in Trial of new Drug

A new drug has been shown to improve the brain function of Alzheimer's patients and reduce a key protein associated with the disease in the spinal fluid.
News

Scientists Predict new Uses for Existing Drugs from Their Side Effects

Researchers developed a computational method that compares how similar the side effects of different drugs are and predicts how likely the drugs act on the same target molecule.
News

Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease

Phase 2 study shows that Dimebon™ significantly improved cognitive function in patients with mild-to-moderate Huntington’s disease.
News

Evotec’s EVT 101 Well Tolerated in Four Week Higher Repeat Dose Safety Study

The study showed in both young and elderly subjects that EVT 101 was well tolerated up to the highest dose tested.
News

The Wellcome Trust Case Control Consortium Selects Illumina DNA Analysis Products

Illumina's Infinium HD Human1M-Duo BeadChip to be used to analyze 90,000 DNA samples collected from study participants.
Advertisement